Seabelife SAS
Seabelife SAS

French Firm Secures €15m Grant for Breakthrough AMD Drug
BIOT
🌊🔬 Seabelife SAS granted €1.5m to develop groundbreaking drug for advanced dry AMD, aiming for clinical trials by Q12026.
Seabelife SAS

🌊🔬 Seabelife SAS granted €1.5m to develop groundbreaking drug for advanced dry AMD, aiming for clinical trials by Q12026.